Simultaneous quantitative detection of afatinib, erlotinib, gefitinib, icotinib, osimertinib and their metabolites in plasma samples of patients with non-small cell lung cancer using liquid chromatography-tandem mass spectrometry
Xin Xiong, Yuanyuan Zhang, Ziyu Wang, Congya Zhou, Ping Yang, Xin Du, Li Yang, Wei Liu
Topics & Concepts
AfatinibOsimertinibErlotinibGefitinibLung cancerChromatographyEpidermal growth factor receptorChemistryIon suppression in liquid chromatography–mass spectrometryTandem mass spectrometryTherapeutic drug monitoringLiquid chromatography–mass spectrometryMass spectrometryPharmacologyDrugMedicineOncologyReceptorBiochemistryLung Cancer Treatments and MutationsChronic Myeloid Leukemia TreatmentsFibroblast Growth Factor Research